Review our resources for client conversations.
Help clients understand how our distinct business model funds innovative medical research.
We're always looking for exceptional team members.
By Mike Liss - April 17, 2018
It’s been a rough period for value. With the value index underperforming the growth index in large cap stocks by 2,000 basis points over the past year, I would say this is likely the most we’ve been out of favor since I started in 1998.
But the value strategy is still where my passion lies, and I see plenty of opportunity on the horizon. Right now, my focus is on energy. Healthcare is also on my radar, and specifically pharmaceuticals and medical technology. In this quarter’s outlook, I focus on that and why bottom-up investors still pay attention to the top down.
Veteran investment manager has a record of creating value for investors.
Off-price retailers offer customers the thrill of the hunt, making them an attractive investment theme among growth stocks.
March 11, 2019
Despite the slowdown in global gross domestic product, global value equity portfolio manager Mike Liss believes a recession is unlikely.
Tariffs. Rising rates. Geopolitical turmoil. None of this deters Sr. Portfolio Manager Mike Liss on his mission to turn high-quality companies underperforming into shareholder return. See which industries are on his radar this quarter.
April 17, 2018
Value equity Sr. PM Mike Liss sees good risk-reward opportunities in the energy and pharmaceutical sectors in 2018.
January 05, 2018
It's been a tough year for value investors, but VP and Sr. Portfolio Manager Michael Liss sees risk-rewards in energy and consumer staples.
November 02, 2017
The opinions expressed are those of American Century Investments (or the portfolio manager) and are no guarantee of the future performance of any American Century Investments' portfolio. This material has been prepared for educational purposes only. It is not intended to provide, and should not be relied upon for, investment, accounting, legal or tax advice.